• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® TAG® THORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® TAG® THORACIC ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGT2610
Device Problem Insufficient Information (3190)
Patient Problems Embolism (1829); Renal Failure (2041); Test Result (2695)
Event Date 04/01/2010
Event Type  Injury  
Event Description
On (b)(6) 2010, the patient underwent endovascular repair of a thoracic aortic aneurysm using two gore® tag® thoracic endoprostheses (tgt2610/7460930 and tgt2815/7583174).A conduit was built in the left common femoral artery, and two stent grafts were advanced from the conduit and deployed.It was revealed that the renal arteries were embolized during the procedure, causing renal insufficiency.Pre-procedure creatinine was measured to be 2.02 mg/dl.Diuretics were administered to treat the renal insufficiency, and the procedure was concluded.On (b)(6) 2010, the patient was discharged of the hospital.The embolism of renal arteries and the renal insufficiency had persisted with pre-discharge creatinine measured to be 2.82 mg/dl.Aneurysm diameter was 58mm.Later in three more follow-up studies performed, the embolism of renal arteries and the renal insufficiency had still persisted, but the patient was monitored.Aneurysm diameter had shrunk to 41mm.On (b)(6) 2013, in three-year follow-up study, it was revealed that the embolism of renal arteries had been resolved.Aneurysm diameter was 38mm.On (b)(6) 2014, in four-year follow-up study, aneurysm diameter was 33mm.The renal insufficiency had still persisted, but a wait-and-watch approach had been continued.It was reported that prior to the initial procedure, circumferential thrombus had been present in the thoracic and abdominal aorta.
 
Manufacturer Narrative
The review of the manufacturing paperwork verified that this lot met all pre-release specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® TAG® THORACIC ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WOODY SPRINGS B/P
3450 w. kiltie lane
flagstaff AZ 86001
Manufacturer Contact
yutaka uchiya
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key4886969
MDR Text Key6262311
Report Number2017233-2015-00395
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 06/22/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/31/2012
Device Catalogue NumberTGT2610
Device Lot Number7460930
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received07/02/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/01/2010
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
(B)(4)
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age69 YR
Patient Weight58
-
-